Jan 21, 2026· Comment from Consumer Healthcare Products Association· FDA-2025-D-5107-0276
Comments for Menstrual Products – Performance Testing and Labeling Recommendations Draft Guidance (attached)
FDANonrulemakingFDA-2025-D-5107
Menstrual Products - Labeling and Performance Testing Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
RIN
—
Last modified
Jan 8, 2026
Comment window
closed 193d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jan 21, 2026 and Jan 21, 2026. 0 other organizations filed here. The comment window closed 193d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
Open
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%